TAPI NL BV

Overview

TAPI NL BV is an active pharmaceutical ingredient (API) supplier with 330 active FDA Type II Drug Master Files, covering 5-FLUOROURACIL; ABIRATERONE ACETATE; AFATINIB DIMALEATE; ALBUTEROL SULPHATE (SALBUTAMOL); ALCLOMETASONE DIPROPIONATE; ALENDRONATE MONOSODIUM TRIHYDRATE.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances TAPI NL BV is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

TAPI NL BV holds 334 active (334 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• FIDAXOMICINActive2026-05-27
• ZAVEGEPANT HYDROCHLORIDEActive2026-04-27
• MAVACAMTENActive2026-03-12
• IXAZOMIB CITRATEActive2026-02-04
• PALIPERIDONE PALMITATE STERILEActive2025-12-22
• TIRZEPATIDEActive2025-12-15
• SEMAGLUTIDEActive2025-12-10
• TAPINAROFActive2025-11-30
• PACRITINIB CITRATEActive2025-09-07
• SOTORASIBActive2025-07-15
• APIXABAN PActive2025-06-17
• BELUMOSUDIL MESYLATEActive2025-05-25
• OLANZAPINE FORM IIActive2025-04-02
• SAMIDORPHAN L-MALATEActive2024-12-19
• TRILACICLIBActive2024-09-05

Showing 15 of 334 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to TAPI NL BV in our records. PharmaTek screens the full directory against live FDA enforcement data.